Notice of Results
London, 11 November 2019
Georgia Healthcare Group PLC notice of 3Q and 9M 2019 Results
Georgia Healthcare Group PLC ("GHG") will publish its financial results for 3Q and 9M 2019 at 07:00 London time on Wednesday, 13 November 2019. The results announcement will be available on GHG's website at ghg.com.ge. An investor/analyst conference call, organised by GHG, will be held on Wednesday, 13 November 2019, at 14:00 UK / 15:00 CET / 09:00 U.S Eastern Time. The duration of the call will be 60 minutes and will consist of a 15-minute update and a 45-minute Q&A session.
|
| ||||||||||||||||||||||||||||||||||||
|
|
Name of authorised official of issuer responsible for making notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 18 hospitals and 34 clinics. GHG is the single largest market participant, accounting for 24% of total hospital bed capacity in the country, as of 30 June 2019. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 30% market share by revenue. GHG is the second largest provider of medical insurance in Georgia with a 31% market share based on net insurance premiums earned and approximately c.230,000 insurance customers. GHG employed a total of c.16,200 people as at 30 June 2019, including c.3,600 physicians and 3,000 pharmacists.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze | Irakli Gogia | Ketevan Kalandarishvili |
CEO | CFO | Head of Investor Relations |
+995 322 550505 (5077) | +995 322 550505 (5088) | +995 322 550505 (5079) |
This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.